Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Genedrive News

    0,045 € +25,00% +0,009 €
    08:05:49 Uhr Frankfurt aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A0ML2T
    ISIN: GB00B1VKB244
    Typ: Aktie

    Genedrive News

    05.02.20 - DGAP
    Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult
    Hardman & Co Research Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult 05-Feb-2020 / 07:15 GMT/BST Hardman & Co ...
    21.11.19 - DGAP
    Hardman & Co Research: genedrive plc (GDR): Regulatory hurdle leaped: hearing loss assay
    Hardman & Co Research Hardman & Co Research: genedrive plc (GDR): Regulatory hurdle leaped: hearing loss assay 21-Nov-2019 / 12:30 GMT/BST Hardman & Co Res earch ...
    28.10.19 - DGAP
    Hardman & Co Research: genedrive plc (GDR): Acceleration of news flow expected
    Hardman & Co Research Hardman & Co Research: genedrive plc (GDR): Acceleration of news flow expected 28-Oct-2019 / 07:30 GMT/BST Hardman & Co Res earch ...
    18.07.19 - DGAP
    Hardman & Co Research: genedrive plc (GDR): Hepatitis C market frustrations
    Hardman & Co Research Hardman & Co Research: genedrive plc (GDR): Hepatitis C market frustrations 18-Jul-2019 / 07:30 GMT/BST
    08.04.19 - DGAP
    Hardman & Co Research: genedrive plc (GDR): First commercial sales in new focus area: bio-threats
    Hardman & Co Research Hardman & Co Research: genedrive plc (GDR): First commercial sales in new focus area: bio-​threats 08-Apr-2019 / 10:53 GMT/BST
    11.12.18 - DGAP
    Hardman & Co Research: genedrive plc (GDR): Accelerating into fiscal 2019 with first sales
    Hardman & Co Research Hardman & Co Research: genedrive plc (GDR): Accelerating into fiscal 2019 with first sales 11-Dec-2018 / 07:15 GMT/BST
    27.06.18 - DGAP
    Hardman & Co Research: genedrive plc (GDR): Preventing hearing loss in newborns
    Hardman & Co Research Hardman & Co Research: genedrive plc (GDR): Preventing hearing loss in newborns 27-Jun-2018 / 07:15 GMT/BST
    12.04.18 - DGAP
    Hardman & Co Research: genedrive plc (GDR): Progressing commercialisation plans
    Hardman & Co Hardman & Co Research: genedrive plc (GDR): Progressing commercialisation plans 12-Apr-2018 / 09:51 GMT/BST
    13.01.16 - PR Newswire
    Epistem Appoints David Budd as Chief Executive Officer
    Epistem Appoints David Budd as Chief Executive Officer PR Newswire
    13.01.16 - PR Newswire
    Epistem Appoints David Budd as Chief Executive Officer
    Epistem Appoints David Budd as Chief Executive Officer PR Newswire
    17.11.09 - Aktiencheck
    Epistem Gewinne mitnehmen - Global Biotech Investing
    Die Experten von "Global Biotech Investing" raten bei der Aktie von Epistem die Gewinne in trockene Tücher zu packen. Ende März 2009 hätten die Experten den Titel erstmal mit ...
    02.06.09 - Hugin
    Epistem Presents Further Data Supporting Its Plucked Hair BiomarkerTechnology at the Institute of Cancer Research Centenary Conference
    Data on the effects of gemcitabine on epithelial tissue released MANCHESTER, UNITED KINGDOM--(Marketwire - June 02, 2009) - Epistem plc (LSE: EHP), the UK biotechnology ...
    20.04.09 - Hugin
    Epistem Present at AACR Meeting in Denver
    MANCHESTER, UNITED KINGDOM--(Marketwire - April 20, 2009) - Epistem plc (LSE: EHP), the UK biotechnology and contract research company, have presented results from their ...
    14.04.09 - Hugin
    Epistem to Present Erlotinib Biomarker Data at AACR Meeting
    MANCHESTER, UNITED KINGDOM--(Marketwire - April 14, 2009) - Epistem plc (LSE: EHP), the UK biotechnology and contract research company, will present results from its ...
    24.03.09 - Aktiencheck
    Epistem sehr gute Entwicklung - Global Biotech Investing
    Nach Angaben der Experten von "Global Biotech Investing" hat sich die Aktie von Epistem in der jüngeren Vergangenheit sehr gut entwickelt. Die Aussicht, bereits nächstes Jahr ...
    07.04.08 - Hugin
    Epistem to Announce Data on Its Stem Cell Cancer Assays at AACR
    MANCHESTER, UK--(Marketwire - April 04, 2008) - Epistem Plc (LSE: EHP), the UK epithelial stem cell company, announced today that data on its cancer stem cell assays will be ...
    07.04.08 - Hugin
    Epistem to Announce Data on Its Stem Cell Cancer Assays at AACR
    MANCHESTER, UK--(Marketwire - April 04, 2008) - Epistem Plc (LSE: EHP), the UK epithelial stem cell company, announced today that data on its cancer stem cell assays will be ...

    Newssuche

    Videos

    09:30 Uhr +23,58%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »